Shares of Interpace Biosciences Inc. (IDXG) are up 20% in pre-market today, after the company announced that its subsidiary, Interpace Diagnostics, has entered into a contract with Avalon Healthcare Solutions, a specialty benefit management company with more than 3 million members, focused on laboratory testing. Terms remain undisclosed.
from RTT - Before the Bell https://ift.tt/2W6DxEq
via IFTTT
No comments:
Post a Comment